Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The Factors Influencing Galectin-3 Levels in Acute Coronary Syndrome with Decreased Left Ventricular Function

The Factors Influencing Galectin-3 Levels in Acute Coronary Syndrome with Decreased Left... References1. Lok DJ, Lok SI, Bruggink-Andre de la Porte PW, et al. Galectin 3 is an independent marker for ventricular remodeling and mortality in patients with chronic hart failure. Clin Res Cardiol 2013;102:103-10 https://doi.org/10.1007/s00392-012-0500-y2. Ho JE, Yin X, Levy D, et al. Galectin 3 and incident atrial fibrillation in the community. Am Heart J.2014;167:729-34 https://doi.org/10.1016/j.ahj.2014.02.0093. Szadkowska I, Wlazeł RN, Migała M, et al. The association between galectin-3 and occurrence of reinfarction early after first myocardial infarction. Biomarkers. 2013;18:655-9. https://doi.org/10.3109/1354750X.2013.8408014. Sanchez-Mas J, Lax A, Asensio-Lopez MC, et al. Galectin-3 expression in cardiac remodeling after myocardial infarction. Int J Cardiol. 2014;172:e98-e101. https://doi.org/10.1016/j.ijcard.2013.12.1295. Weir R, Petrie C, Murphy A, et al. Galectin-3 and Cardiac Function in Survivors of Acute Myocardial Infarction Clinical Perspective. Circ Heart Fail. 2013;6:492-498 https://doi.org/10.1161/CIRCHEARTFAILURE.112.0001466. De Boer RA, van Veldhusein DJ, Cansevoort RT, et al. The fibrosis marker galectin-3 and outcome in the general population. J Inter Med. 2012;272:55-64 https://doi.org/10.1111/j.1365-2796.2011.02476.x7. Tian L, Chen K, Cao J, et al. Galectin-3-induced oxidized low-density lipoprotein promotes the phenotypic transformation of vascular smooth muscle cells. MolMed Reps. 2015: 12; 4995-5002 https://doi.org/10.3892/mmr.2015.40758. Van der Velde, Lexis CP, Meijers WC, et al. Galectin-3 and sST2 in prediction of left ventricular ejection fraction after myocardial infarction. Clin Chim Acta. 2016;452:50-7 https://doi.org/10.1016/j.cca.2015.10.0349. Grandin EW, Jarolim P, Murphy SA, et al. Galectin-3 and the Development of Heart failure after Acute Coronary Syndrome: Pilot Experience from PROVE IT-TIMI 22. Clin. Chem 2012;58:267-73 https://doi.org/10.1373/clinchem.2011.17435910. Zou R, Kneller J, Leon LJ, Nattel S. Substrate size as a determinant of fibrillatory activity maintenance in a mathematical model of canine atrium. Am J Physiol Heart Circ Physiol 2005;289:H1002–H1012 https://doi.org/10.1152/ajpheart.00252.200511. Crenshaw BS, Ward SR, Granger CB, et al. Atrial fibrillation in the settings of Acute Mycardial infarction: The GUSTO-I Experience. JACC. 1997;30:406-413 https://doi.org/10.1016/S0735-1097(97)00194-0 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Acta Facultatis Medicae Naissensis de Gruyter

The Factors Influencing Galectin-3 Levels in Acute Coronary Syndrome with Decreased Left Ventricular Function

Download PDF
10 pages

Loading next page...
 
/lp/de-gruyter/the-factors-influencing-galectin-3-levels-in-acute-coronary-syndrome-Chlqxo9Vo0
Publisher
de Gruyter
Copyright
© 2017 Olivera Andrejić et al., published by De Gruyter Open
ISSN
2217-2521
eISSN
2217-2521
DOI
10.1515/afmnai-2017-0034
Publisher site
See Article on Publisher Site

Abstract

References1. Lok DJ, Lok SI, Bruggink-Andre de la Porte PW, et al. Galectin 3 is an independent marker for ventricular remodeling and mortality in patients with chronic hart failure. Clin Res Cardiol 2013;102:103-10 https://doi.org/10.1007/s00392-012-0500-y2. Ho JE, Yin X, Levy D, et al. Galectin 3 and incident atrial fibrillation in the community. Am Heart J.2014;167:729-34 https://doi.org/10.1016/j.ahj.2014.02.0093. Szadkowska I, Wlazeł RN, Migała M, et al. The association between galectin-3 and occurrence of reinfarction early after first myocardial infarction. Biomarkers. 2013;18:655-9. https://doi.org/10.3109/1354750X.2013.8408014. Sanchez-Mas J, Lax A, Asensio-Lopez MC, et al. Galectin-3 expression in cardiac remodeling after myocardial infarction. Int J Cardiol. 2014;172:e98-e101. https://doi.org/10.1016/j.ijcard.2013.12.1295. Weir R, Petrie C, Murphy A, et al. Galectin-3 and Cardiac Function in Survivors of Acute Myocardial Infarction Clinical Perspective. Circ Heart Fail. 2013;6:492-498 https://doi.org/10.1161/CIRCHEARTFAILURE.112.0001466. De Boer RA, van Veldhusein DJ, Cansevoort RT, et al. The fibrosis marker galectin-3 and outcome in the general population. J Inter Med. 2012;272:55-64 https://doi.org/10.1111/j.1365-2796.2011.02476.x7. Tian L, Chen K, Cao J, et al. Galectin-3-induced oxidized low-density lipoprotein promotes the phenotypic transformation of vascular smooth muscle cells. MolMed Reps. 2015: 12; 4995-5002 https://doi.org/10.3892/mmr.2015.40758. Van der Velde, Lexis CP, Meijers WC, et al. Galectin-3 and sST2 in prediction of left ventricular ejection fraction after myocardial infarction. Clin Chim Acta. 2016;452:50-7 https://doi.org/10.1016/j.cca.2015.10.0349. Grandin EW, Jarolim P, Murphy SA, et al. Galectin-3 and the Development of Heart failure after Acute Coronary Syndrome: Pilot Experience from PROVE IT-TIMI 22. Clin. Chem 2012;58:267-73 https://doi.org/10.1373/clinchem.2011.17435910. Zou R, Kneller J, Leon LJ, Nattel S. Substrate size as a determinant of fibrillatory activity maintenance in a mathematical model of canine atrium. Am J Physiol Heart Circ Physiol 2005;289:H1002–H1012 https://doi.org/10.1152/ajpheart.00252.200511. Crenshaw BS, Ward SR, Granger CB, et al. Atrial fibrillation in the settings of Acute Mycardial infarction: The GUSTO-I Experience. JACC. 1997;30:406-413 https://doi.org/10.1016/S0735-1097(97)00194-0

Journal

Acta Facultatis Medicae Naissensis – de Gruyter

Published: Dec 1, 2017

References

  • Lok Lok de la Porte is an independent marker for ventricular remodeling and mortality in patients with chronic hart failure https org
    Bruggink
  • Mas expression in cardiac remodeling after myocardial infarction https org
    Sanchez
  • - induced oxidized low - density lipoprotein promotes the phenotypic transformation of vascular smooth muscle cells Reps https org
    Tian
  • der WC sST in prediction of left ventricular ejection fraction after myocardial infarction https org
    Van
  • Atrial fibrillation in the settings of Acute Mycardial infarction : The GUSTO Experience https org
    Crenshaw
  • and Cardiac Function in Survivors of Acute Myocardial Infarction Clinical Perspective Fail https org
    Weir
  • Substrate size as a determinant of fibrillatory activity maintenance in a mathematical model of canine atrium https org
    Zou
  • The association between galectin and occurrence of reinfarction early after first myocardial infarction https org
    Szadkowska
  • The fibrosis marker galectin outcome in the general population Inter https org
    De Boer
  • incident atrial fibrillation in the community https org
    Ho
  • the Development of Heart failure after Acute Coronary Syndrome : Pilot Experience from PROVE IT - https org
    Grandin